MONDAY, Jan. 10, 2022 (HealthDay News) — Medicare has been told to reassess a significant premium increase it had announced that largely stemmed from the expensive new Alzheimer’s drug Aduhelm. U.S. Health and Human Services Secretary Xavier Becerra’s directive, which was announced on Monday, comes shortly after Aduhelm maker BiogenContinue Reading

MONDAY, Jan. 10, 2022 (HealthDay News) — Researchers say they’ve uncovered a clue to why the Omicron variant spreads COVID-19 so much more rapidly than its predecessors. People who are infected but have no symptoms are still far more likely to infect others than they would have been with earlierContinue Reading

MONDAY, Jan. 10, 2022 (HealthDay News) — For people newly diagnosed with advanced melanoma, a combination of two immunotherapy drugs can double the amount of time their cancer remains progression-free, a clinical trial has found. The treatment combines two drugs known as immune checkpoint inhibitors. One, called nivolumab (Opdivo), isContinue Reading

MONDAY, Jan. 10, 2022 (HealthDay News) — Vaccination is still the best way to protect someone from COVID-19, but new research suggests that immune system activation of T-cells by common colds may offer some cross-protection. The study might also provide a blueprint for a second-generation, universal vaccine that could preventContinue Reading